Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca
This survey study (n=1947) indicates an association between reduced current tobacco and alcohol use and attendance of religious ayahuasca ceremonies. Lifetime use of these substances, however, was higher in the ceremony-attending group in most age groups.
Authors
- Luiz Tófoli
- Michael Bogenschutz
- Paulo Barbosa
Published
Abstract
The aims of this study were to assess the impact of ceremonial use of ayahuasca-a psychedelic brew containing N,N-dimethyltryptamine (DMT) and β-carboline -and attendance at União do Vegetal (UDV) meetings on substance abuse; here we report the findings related to alcohol and tobacco use disorder. A total of 1,947 members of UDV 18+ years old were evaluated in terms of years of membership and ceremonial attendance during the previous 12 months. Participants were recruited from 10 states from all major regions of Brazil. Alcohol and tobacco use was evaluated through questionnaires first developed by the World Health Organization and the Substance Abuse and Mental Health Services Administration. Analyses compared levels of alcohol and tobacco use disorder between the UDV and a national normative sample (n = 7,939). Binomial tests for proportions indicated that lifetime use of alcohol and tobacco was higher in UDV sample compared to the Brazilian norms for age ranges of 25-34 and over 34 years old, but not for the age range of 18-24 years old. However, current use disorders for alcohol and tobacco were significantly lower in the UDV sample than the Brazilian norms. Regression analyses revealed a significant impact of attendance at ayahuasca ceremonies during the previous 12 months and years of UDV membership on the reduction of alcohol and tobacco use disorder.
Research Summary of 'Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca'
Introduction
Alcohol and tobacco use disorders remain major global public health problems, causing substantial morbidity and mortality despite a wide array of current treatments. Earlier research has suggested that ritual use of ayahuasca, a brew containing N,N-dimethyltryptamine (DMT) and β-carbolines, may be associated with reduced substance-use problems. Small case-control and cross-sectional studies, plus some prospective and programmatic reports, have reported lower recent alcohol and other drug use among members of religious ayahuasca groups such as União do Vegetal (UDV), Santo Daime and Barquinha, although findings have been mixed and many studies were limited by small samples, heterogeneous settings and non-rigorous designs. Ramchandani and colleagues set out to extend this evidence by analysing patterns of alcohol and tobacco use and disorder in a much larger sample of UDV members drawn from 10 Brazilian states. The study compared prevalence of lifetime and current alcohol and tobacco use and substance-use disorder in the UDV sample with a national Brazilian normative survey, and examined whether recent ceremonial attendance and years of UDV membership were associated with lower likelihood of alcohol and tobacco use and disorder.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Barbosa, P. C. R., Tófoli, L. F., Bogenschutz, M. P., Hoy, R., Berro, L. F., Marinho, E. A. V., Areco, K. N., & Winkelman, M. J. (2018). Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca. Frontiers in Psychiatry, 9. https://doi.org/10.3389/fpsyt.2018.00136
References (14)
Papers cited by this study that are also in Blossom
Doering-Silveira, E., Grob, C. S., Dobkin de Rios, M. et al. · Journal of Psychoactive Drugs (2005)
Fábregas, J. M., González, D., Fondevila, S. et al. · Drug and Alcohol Dependence (2010)
Barbosa, P., Strassman, R. J., da Silveira, D. X. et al. · Comprehensive Psychiatry (2016)
Halpern, J. H., Sherwood, A. R., Passie, T. et al. · Medical Science Monitor (2008)
Thomas, G., Lucas, P., Rielle Capler, N. et al. · Current Drug Abuse Reviews (2013)
Lawn, W., Hallak, J. E., Crippa, J. A. et al. · Scientific Reports (2017)
Nunes, A. A., Dos Santos, R. G., Osório, F. L. et al. · Journal of Psychoactive Drugs (2016)
Winkelman, M. J. · Current Drug Abuse Reviews (2014)
Cakic, V., Potkonyak, J., Marshall, A. · Drug and Alcohol Dependence (2010)
McKenna, D., Towers, G. H., Abbott, F. · Journal of Ethnopharmacology (1984)
Show all 14 referencesShow fewer
Liester, M. B., Prickett, J. I. · Journal of Psychoactive Drugs (2012)
Gable, R. S. · Addiction (2006)
Domínguez-Clavé, E., Soler, J., Elices, M. et al. · Brain Research Bulletin (2016)
McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)
Cited By (17)
Papers in Blossom that reference this study
Fonseca, A. M., Dos Santos, R. G., Santos, F. P. et al. · European Archives of Psychiatry and Clinical Neuroscience (2024)
Zafar, R., Siegel, M., Harding, R. et al. · Frontiers in Psychiatry (2023)
Perkins, D., Pagni, B. A., Sarris, J. et al. · Frontiers in Pharmacology (2022)
Calleja-Conde, J., Morales-García, J. A., Echeverry-Alzate, V. et al. · Addiction Biology (2022)
Rodriguez, L., Lopez, A., Moyna, G. et al. · ACS Omega (2022)
Serra, Y. A., Barros-Santos, T., Anjos-Santos, A. et al. · Psychopharmacology (2022)
Maia, L. O., Massarentti, C. M., Tófoli, L.F. · Psychopharmacology (2022)
Jones, G. M., Nock, M. K. · Scientific Reports (2022)
Mangini, P., Averill, L. A., Davis, A. K. · Journal of Psychedelic Studies (2022)
Perkins, D., Opaleye, E. S., Simonová, H. et al. · Drug and Alcohol Review (2021)
Show all 17 papersShow fewer
Gilbert, C. S., Earleywine, M., Mian, M. N. et al. · Journal of Psychedelic Studies (2021)
Rodrigues, L. S., Rossi, G. N., Rocha, J. M. et al. · European Archives of Psychiatry and Clinical Neuroscience (2021)
Maia, L. O., Daldegan-Bueno, D., Tófoli, L.F. · Journal of Psychoactive Drugs (2020)
Andersen, K. A. A., Carhart-Harris, R. L., Nutt, D. J. et al. · Acta Psychiatrica Scandinavica (2020)
Dos Santos, R. G., Hallak, J. E. · Neuroscience and Biobehavioral Reviews (2020)
Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)
Ona, G., Kohek, M., Massaguer, T. et al. · Journal of Psychoactive Drugs (2019)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.